Leave your feedback Share Copy URL https://gographicsoutput.com/video/zycd2rBKFx1.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter The Next Phase Of The Obesity Drug Race [GiPfmZxd0IU] Health Updated on August 05, 2026 EDT — Published on August 05, 2026 EDT Five years after Wegovy’s FDA approval, the obesity drug market has evolved rapidly. Novo Nordisk and Eli Lilly introduced GLP-1 pills this year and others like Structure Therapeutics and Zealand Pharma are trying to fight for market share. But the space is getting crowded. CNBC’s Angelica Peebles has the story from the American Diabetic Association’s conference in New Orleans. Chapters: 00:00 - 00:37 Introduction 00:38 - 03:10 Mounting competition 03:11 - 5:38 Next steps in innovation Reporting by: Angelica Peebles Senior Field Producer: Leanne Miller Edited by: Darren Geeter Animation by: Jason Reginato, Emily Park Senior Managing Producer: Tala Hadavi Additional Footage: Getty Images » Subscribe to CNBC: » Subscribe to CNBC TV: About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Want to get ahead at work? Then you need to learn how to make effective small talk. In CNBC’s new online course, How To Talk To People At Work, expert instructors teach you how to use everyday conversation to gain visibility, build meaningful relationships and advance your career. Sign up now: Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Instagram: Follow CNBC News on Facebook: Follow CNBC on Threads: Follow CNBC News on X: Follow CNBC on WhatsApp: #CNBC The Next Phase Of The Obesity Drug Race NI8nxP3LpJy TPtdU41Z5fN n6ViRPrdA61 ML4iZPJk3eq CKk6pRZkc93
Five years after Wegovy’s FDA approval, the obesity drug market has evolved rapidly. Novo Nordisk and Eli Lilly introduced GLP-1 pills this year and others like Structure Therapeutics and Zealand Pharma are trying to fight for market share. But the space is getting crowded. CNBC’s Angelica Peebles has the story from the American Diabetic Association’s conference in New Orleans. Chapters: 00:00 - 00:37 Introduction 00:38 - 03:10 Mounting competition 03:11 - 5:38 Next steps in innovation Reporting by: Angelica Peebles Senior Field Producer: Leanne Miller Edited by: Darren Geeter Animation by: Jason Reginato, Emily Park Senior Managing Producer: Tala Hadavi Additional Footage: Getty Images » Subscribe to CNBC: » Subscribe to CNBC TV: About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Want to get ahead at work? Then you need to learn how to make effective small talk. In CNBC’s new online course, How To Talk To People At Work, expert instructors teach you how to use everyday conversation to gain visibility, build meaningful relationships and advance your career. Sign up now: Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Instagram: Follow CNBC News on Facebook: Follow CNBC on Threads: Follow CNBC News on X: Follow CNBC on WhatsApp: #CNBC The Next Phase Of The Obesity Drug Race NI8nxP3LpJy TPtdU41Z5fN n6ViRPrdA61 ML4iZPJk3eq CKk6pRZkc93